Three Massachusetts biotechs are planning to go public this week with a collective goal of raising $600 million, marking a ...

Generac settles construction-site explosion suit for $206M Generac stock spikes on potential for data center products Generac ...

Rendering isn’t always immediate or complete. Learn where no-JavaScript fallbacks still protect critical content, links, and ...

Researchers have developed an AI image generator that produces images in just four steps, rather than dozens. This could bring fast, private image generation directly to consumer devices. When you ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Elon Musk's artificial intelligence company xAI is donating 500 generators to Nashville. In a post on X, Gov. Bill Lee thanked Musk and the company. "Tennesseans without power need immediate help," ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...